Parkinson’s disease is one of the most common neurodegenerative conditions worldwide. In Colombia, more than 220,000 people suffer from it, according to the Colombian Association of Neurology.

NOTICIAS
NEWS
¡NO TE PIERDAS LA ÚLTIMA HORA EN TARKUS PHARMA LAB!
DON’T MISS THE LAST HOUR AT TARKUS PHARMA LAB!
Parkinson’s disease is one of the most common neurodegenerative conditions worldwide. In Colombia, more than 220,000 people suffer from it, according to the Colombian Association of Neurology.
Research into medicinal cannabis continues to progress, and Tarkus Pharma Lab, in collaboration with the Complutense University of Madrid, has developed an innovative preclinical study on the effects of CBD on aging and cellular health. This study, presented at the...
ABOUT US
¡Conectemos para Innovar!
What do our partners say?
Our pharmaceutical-grade production plant is a pioneer in Colombia.
Located in the Tocancipá Free Trade Zone, our facility is certified by GMP (INVIMA) and ANVISA (Brazil), ensuring the highest quality standards for highly regulated markets.
This strategic location allows us to operate efficiently, benefit from tax incentives, and enjoy preferential access to exports—positioning Tarkus Pharma Lab as a key player in the pharmaceutical cannabis industry.
SOBRE NOSOTROS
¿Qué dicen
nuestros partners?
Nuestra planta de producción de grado farmacéutico es pionera en Colombia.
Ubicada en la zona franca de Tocancipá, nuestra planta cuenta con certificación GMP (INVIMA) y ANVISA (Brasil), garantizando el más alto estándar de calidad para mercados altamente regulados.
Esta ubicación estratégica nos permite operar con eficiencia, beneficios fiscales y acceso preferencial a exportaciones, consolidando a Tarkus Pharma Lab como un actor clave en la industria farmacéutica del cannabis.